0001225208-22-003724.txt : 20220301 0001225208-22-003724.hdr.sgml : 20220301 20220301175532 ACCESSION NUMBER: 0001225208-22-003724 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220226 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUSMAN SALLY CENTRAL INDEX KEY: 0001263544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 22700100 MAIL ADDRESS: STREET 1: 767 FIFTH AVE STREET 2: EOTIC LAWDER CORP CITY: NEW YORK STATE: NY ZIP: 10153 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2022-02-26 0000078003 PFIZER INC PFE 0001263544 SUSMAN SALLY PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Executive Vice President Common Stock 2022-02-26 4 M 0 63580.0000 25.6000 A 172880.0000 D Common Stock 2022-02-26 4 F 0 18745.0000 47.7200 D 154135.0000 D Common Stock 2022-02-26 4 F 0 29685.0000 50.6400 D 124450.0000 D Common Stock 747.0000 I By Rule 16b-3 Plan Stock Appreciation Rights 25.6000 2022-02-26 4 M 0 63580.0000 0.0000 D 2022-02-26 2022-02-26 Common Stock 63580.0000 0.0000 D Phantom Stock Units 2022-02-28 4 A 0 58623.0000 0.0000 A Common Stock 58623.0000 80225.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Price is the closing price of Pfizer common stock on February 25, 2022. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Each unit represents one phantom share of common stock. The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan. The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Susan E. Grant, by power of atty., for Sally Susman 2022-03-01